Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-07

Clinical Trial Update: Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours [Phase 2]

View source ↗

Summary

Phase 2 trial investigating abscopal effect of radiotherapy combined with rhGM-CSF for advanced thymic epithelial tumors (thymoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiotherapy
  • RhGM-CSF (sargramostim (recombinant human granulocyte-macrophage colony-stimulating factor))

Snippet

Sponsor: Shanghai Cancer Hospital, China | Conditions: Thymoma | Phase 2 | Status: UNKNOWN